Technique for the Early Detection of Drug-Resistant HBV DNA during Antiviral Therapy

By  

Intervirology, Vol. 51, Iss. 1, 2008-06 ,pp. : 7-10

Karger

Access to resources Recommend Favorite

P140: Drug‐drug interactions with novel all oral interferon free antiviral agents ‐ all issues solved?

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 89-90

John Wiley & Sons Inc

Access to resources Recommend Favorite

The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis C

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1365-1372

John Wiley & Sons Inc

Access to resources Recommend Favorite

Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 176-183

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 805-815

John Wiley & Sons Inc

Access to resources Recommend Favorite